Protease Resistant Insulin Analogues

Patent No. EP2074141 (titled "Protease Resistant Insulin Analogues") was filed by Novo Nordisk on Sep 20, 2007. The application was issued on Aug 10, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELI LILLYMay 10, 2017KENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2074141

NOVO NORDISK
Application Number
EP07820423A
Filing Date
Sep 20, 2007
Status
Revoked
Feb 18, 2022
Publication Date
Aug 10, 2016